TP53 and colorectal carcinoma: The hypermethylation of the MGMT gene promoter and the resulting inactivation of protein expression play a key role in the early stages of colorectal cancer (CRC) development, as it is associated with an increase in G>A point mutations in other cancer-associated genes, such as KRAS and TP53 [4].